🔎 Trials Near Me

Utama › Karsinoma Sel Merkel › California

Kajian klinikal Karsinoma Sel Merkel di California

5 kajian untuk Karsinoma Sel Merkel sedang mencari peserta di lokasi di California.

Bandar di California

Teks kajian rasmi (Bahasa Inggeris)

Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell Cancer

  • City of Hope, Duarte
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT05583708

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

  • Precision NextGen Oncology, Beverly Hills
  • OPN Healthcare, Inc, Glendale
  • University of Southern California, Los Angeles
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06047379

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

  • UC San Diego Moores Cancer Center, La Jolla
  • Keck Medicine of USC Koreatown, Los Angeles
  • Los Angeles General Medical Center, Los Angeles
  • dan 1 lagi
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 31 Ogo 2026 · NCT05896839

Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma

  • USC Norris Comprehensive Cancer Center, Los Angeles
  • University of California San Francisco - Helen Diller Family Comprehensive Cancer Center, San Francisco
  • Stanford Health Care - Skin Cancer Program, Stanford
Mengambil pesertaFasa 2/3
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Apr 2026 · NCT06947928

A Beta-only IL-2 ImmunoTherapY Study

  • Sharp Memorial Hospital, San Diego
  • Providence Saint John's Health Center, Santa Monica
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Jul 2025 · NCT05086692

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.